Loading
Latest filing published 16 May 2017 for Protalix BioTherapeutics, Inc., €37k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Moshe Manor has a single filing on record, published on 16 May 2017: an open-market purchase of €37k in Protalix BioTherapeutics, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration